The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients

May 5, 2025 updated by: Bnai Zion Medical Center

Patient Reported Outcomes Following Complementary Medicine Treatments in Hospitalized Patients

This is a randomized, single blinded, interventional trial conducted in patients undergoing elective laparoscopic cholecystectomy, comparing the following three groups: Controls receiving standard-of-care (SoC) only (Group 1); intervention group receiving reflexology and SoC (Group 2); and a group receiving sham reflexology and SoC (Group 3). In all groups, level of preoperative anxiety was evaluated at entry and exit from the Holding Room Area (HRA). The evaluation was carried out using the Visual Analogue Scale for Anxiety (VAS-A) questionnaire.

Study Overview

Status

Completed

Conditions

Detailed Description

Symptomatic patients are referred to CAM treatments by the medical staff of the departments. Patients interested in CAM treatments may receive various CAM treatments such as reflexology, acupuncture, guided imagery and hypnosis, according to patient preference and practitioner availability. Patients are requested to grade the severity of their symptoms on a visual analogue scale (0-100) before treatment and within 3 hours following treatments. Patients who are interested in standard care alone and not interested in CAM treatments grade their symptoms similarly, and serve as a control group. Primary outcomes are symptomatic relief and secondary outcomes are correlations between belief or disbelief in CAM with the primary outcomes.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel
        • Bnai Zion Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Study Population

All hospitalized patients

Description

Inclusion Criteria:

  1. Patients aged 18 years
  2. Undergoing Laparoscopic Cholecysyectomy (LC)

Exclusion criteria:

  1. Patients with a history of obstructive sleep apnea
  2. Contraindication for benzodiazepines
  3. Hemodynamic instability
  4. Leg ulcers
  5. Patients undergoing a LC together with another surgical procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Reflexology
Symptomatic hospitalized people randomized to reflexology on top of standard of care
Reflexology intervention involved a 15-minute treatment in the induction room, provided by three reflexologists from the hospital staff. The reflexology protocol was developed through a Delphi method.
No Intervention: Standard of care only
Symptomatic hospitalized people randomized to standard of care only
Sham Comparator: Sham reflexology
Symptomatic hospitalized people randomized to sham reflexology on top of standard of care
Sham reflexology intervention were given by two complementary medicine practitioners with knowledge in touch therapy (shiatsu) and included 15 minutes of gentle, nonspecific foot massage. Similarly to the true reflexology protocol, the protocol for this treatment was also determined in a consensus-reaching process among a group of four experienced reflexologists.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative Anxiety Expressed in Visual Analogue Scale for Anxiety (VAS-A) From 0 (Asymptomatic: no Anxiety) to 10 Extremely Symptomatic Anxiety
Time Frame: Baseline and 4 hours post treatment: calculated as value at 4 hours post treatment minus value at baseline
Change of VAS-A between baseline and 4 hours post-treatment
Baseline and 4 hours post treatment: calculated as value at 4 hours post treatment minus value at baseline

Secondary Outcome Measures

Outcome Measure
Time Frame
correlations between expectations from CAM as measured on a likert scale (0= disbelief and 5- high belief)and primary outcomes
Time Frame: at baseline evaluation (time 0')
at baseline evaluation (time 0')

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elad Schiff, Prof, Director, Internal Medicine B

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Actual)

December 30, 2020

Study Completion (Actual)

December 30, 2020

Study Registration Dates

First Submitted

July 10, 2012

First Submitted That Met QC Criteria

November 26, 2012

First Posted (Estimated)

November 27, 2012

Study Record Updates

Last Update Posted (Actual)

May 20, 2025

Last Update Submitted That Met QC Criteria

May 5, 2025

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BNZ-0041-09

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Reflexology

Subscribe